Glycation of high-density lipoprotein in type 2 diabetes mellitus

被引:7
作者
Sun Jia-teng [1 ]
Shen Ying [2 ]
Lu An-kang [1 ]
Lu Lin [1 ]
Shen Wei-feng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Ruijin Hosp, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Inst Cardiovasc Dis, Shanghai 200025, Peoples R China
关键词
glycation; high-density lipoprotein; atherosclerosis; diabetes; APOLIPOPROTEIN-A-I; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; NONENZYMATIC GLYCATION; ANTIOXIDANT PROPERTIES; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; ATHEROSCLEROSIS; IMPAIRS; HDL; DYSFUNCTION;
D O I
10.3760/cma.j.issn.0366-6999.20131149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate whether glycation of high-density lipoprotein (HDL) increases cardiovascular risk in patients with type 2 diabetes mellitus by altering its anti-atherogenic property. Data sources Data cited in this review were obtained mainly from Pubmed and Medline in English from 2000 to 2013, with keywords "glycation", "HDL", and "atherosclerosis". Study selection Articles regarding glycation of HDL and its role in atherogenesis in both humans and experimental animal models were identified, retrieved and reviewed. Results Glycation alters the structure of HDL and its associated enzymes, resulting in an impairment of atheroprotective functionality and increased risks for cardiovascular events in type 2 diabetic patients. Conclusion Glycation of HDL exerts a deleterious effect on the development of cardiovascular complications in diabetes.
引用
收藏
页码:4162 / 4165
页数:4
相关论文
共 50 条
  • [21] Relation of Monocyte/High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Type 2 Diabetes Mellitus
    Gao Ya
    Zhang Qiu
    Pan Tianrong
    CLINICAL LABORATORY, 2018, 64 (06) : 901 - 906
  • [22] High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes
    Heier, Martin
    Ofstad, Anne Pernille
    Borja, Mark S.
    Brunborg, Cathrine
    Endresen, Knut
    Gullestad, Lars
    Birkeland, Kdre, I
    Johansen, Odd Erik
    Oda, Michael N.
    ATHEROSCLEROSIS, 2019, 282 : 183 - 187
  • [23] The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review
    Lemmers, Roosmarijn F. H.
    van Hoek, Mandy
    Lieverse, Aloysius G.
    Verhoeven, Adrie J. M.
    Sijbrands, Eric J. G.
    Mulder, Monique T.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (03) : 712 - 724
  • [24] High-density lipoprotein cholesterol in diabetes: Is higher always better?
    Costacou, Tina
    Evans, Rhobert W.
    Orchard, Trevor J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (05) : 387 - 394
  • [25] Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
    Zhongli Chen
    Song Ding
    Yan Ping Wang
    Liang Chen
    Jing Yan Mao
    Ying Yang
    Jia Teng Sun
    Ke Yang
    Journal of Translational Medicine, 18
  • [26] Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
    Calkin, Anna C.
    Drew, Brian G.
    Ono, Akiko
    Duffy, Stephen J.
    Gordon, Michelle V.
    Schoenwaelder, Simone M.
    Sviridov, Dmitri
    Cooper, Mark E.
    Kingwell, Bronwyn A.
    Jackson, Shaun P.
    CIRCULATION, 2009, 120 (21) : 2095 - U60
  • [27] Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol
    Juren, Andrew J.
    Sarwal, Gautamn
    Al-Sarraf, Ahmad
    Vrablik, Michal
    Chan, Darren
    Humphries, Karin H.
    Frohlich, Jiri J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (03) : 194 - 198
  • [28] ASSOCIATIONS BETWEEN TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO AND MICRO- AND MACROANGIOPATHIES IN TYPE 2 DIABETES MELLITUS
    Lee, Mei-Yueh
    Hsiao, Pi-Jung
    Huang, Jiun-Chi
    Hsu, Wei-Hao
    Chen, Szu-Chia
    Chang, Jer-Ming
    Shin, Shyi-Jang
    ENDOCRINE PRACTICE, 2018, 24 (07) : 615 - 621
  • [29] Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
    Bonilha, Isabella
    Zimetti, Francesca
    Zanotti, Ilaria
    Papotti, Bianca
    Sposito, Andrei C.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [30] Speciated High-Density Lipoprotein Biogenesis and Functionality
    Rosales, C.
    Davidson, W. S.
    Gillard, B. K.
    Gotto, A. M., Jr.
    Pownall, H. J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (05)